Evidence map›Paper›PMID 26109329›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2015

First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery.

Nynke S van den Berg, Hervé Simon, Gijs H Kleinjan, Thijs Engelen, Anton Bunschoten, Mick M Welling, Bernard M Tijink, Simon Horenblas, Jacques Chambron, Fijs W B van Leeuwen

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. European journal of nuclear medicine and molecular imaging · 2023
    Pooled it
  4. Trial
  5. Molecular image-guided surgery in gynaecological cancer: where do we stand?European journal of nuclear medicine and molecular imaging · 2024
    Review
  6. Review
  7. Article
  8. Diagnostic accuracy of combined optical- and radio-guided SNB for neck staging of oral squamous cell carcinoma lesions in the anterior oral cavity.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Fluorescence-guided radical prostatectomy.International urology and nephrology · 2022
    Review
  13. Review
  14. Clinical use of an opto-nuclear probe for hybrid sentinel node biopsy guidance: first results.International journal of computer assisted radiology and surgery · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Role of ICG-European journal of nuclear medicine and molecular imaging · 2017
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Nynke S van den BergInterventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, C2-S zone, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Hervé SimonEurorad S.A., 2 Rue Ettore Bugatti, 67201, Eckbolsheim, France.
Gijs H KleinjanInterventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, C2-S zone, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Thijs EngelenInterventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, C2-S zone, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Anton BunschotenInterventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, C2-S zone, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Mick M WellingInterventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, C2-S zone, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Bernard M TijinkDepartment of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Simon HorenblasDepartment of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Jacques ChambronDepartment of Nuclear Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Fijs W B van LeeuwenInterventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, C2-S zone, PO Box 9600, 2300 RC, Leiden, The Netherlands. F.W.B.van_Leeuwen@lumc.nl.
Leiden University Medical Center · NLThe Netherlands Cancer Institute · NLEurorad (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe clinical introduction of the hybrid tracer indocyanine green (ICG)-(99m)Tc-nanocolloid, composed of a radioactive and a near-infrared (NIR) fluorescence component, has created the need for surgical (imaging) modalities that allow for simultaneous detection of both signals. This study describes the first-in-human use of a prototype opto-nuclear probe during sentinel node (SN) biopsy using ICG-(99m)Tc-nanocolloid.

methodsTo allow for fluorescence tracing, a derivative of the conventional gamma probe technology was generated in which two optical fibers were integrated to allow for excitation (785 nm) and emission signal collection (> 810 nm). The ability of this opto-nuclear probe to detect the fluorescence signal of the hybrid tracer ICG-(99m)Tc-nanocolloid was firstly determined ex vivo in (non)SNs samples obtained from 41 patients who underwent hybrid tracer-based SN biopsy in the head and neck or urogenital area. In an in vivo proof-of-concept study in nine of these 41 patients, SNs were localized using combined gamma and fluorescence tracing with the opto-nuclear probe. Fluorescence tracing was performed in a similar manner as gamma tracing and under ambient light conditions.

resultsEx vivo, the gamma tracing option of the opto-nuclear probe correctly identified the SN in all 150 evaluated (non)SN samples. Ex vivo fluorescence tracing in the low-sensitivity mode correctly identified 71.7% of the samples. This increased to 98.9% when fluorescence tracing was performed in the high-sensitivity mode. In vivo fluorescence tracing (high-sensitivity mode) accurately identified the SNs in all nine patients (20 SNs evaluated; 100%).

conclusionThis study demonstrates the first-in-human evaluation of a hybrid modality capable of detecting both gamma and fluorescence signals during a surgical procedure. Fluorescence tracing could be performed in ambient light.

Indexed as

Infrared RaysAgedFemaleFluorescent DyesHumansIndocyanine GreenIntraoperative PeriodMaleMiddle AgedOptical FibersPhantoms, ImagingRadioactive TracersSentinel Lymph Node BiopsySurgery, Computer-AssistedTechnetium Tc 99m Aggregated AlbuminFluorescent DyesIndocyanine GreenRadioactive TracersTechnetium Tc 99m Aggregated Albumintechnetium Tc 99m nanocolloid

Identifiers

PMID26109329
OpenAlexW4238268681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.